Hematology-American Society of Hematology Education Program

Papers
(The H4-Index of Hematology-American Society of Hematology Education Program is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Your chemo is no good here: management of high-risk MCL85
When should gene therapy be considered for transfusion-dependent β-thalassemia patients?73
Labor and delivery: DIC, HELLP, preeclampsia54
Neurological manifestations of MGUS51
Inpatient recognition and management of HLH41
On the horizon: upcoming new agents for the management of ITP35
The varieties of therapeutic experience: navigating treatment options for patients with PNH32
Advances in the diagnosis and management of pediatric Langerhans cell histiocytosis and Rosai-Dorfman disease: therapies, biomarkers, and response assessment28
Challenges and opportunities in the long-term management of immune-mediated TTP27
Inherited thrombophilia and recurrent miscarriage: is there a role for anticoagulation during pregnancy?26
Recognizing, defining, and managing CAR-T hematologic toxicities26
Bispecific antibody therapies24
Mastocytosis demystified24
Anticoagulation at the end of life: whether, when, and how to treat24
Individualized patient care in nodular lymphocyte-predominant Hodgkin lymphoma23
To consolidate or not to consolidate: the role of autologous stem cell transplantation in MCL22
Mutation- and MRD-informed treatment decisions for the transplant-eligible AML patient22
T-cell–based therapies for treating relapsed or refractory mantle cell lymphoma21
Where do immunotherapies stand in management of acute leukemia in adults?21
Has PD-1 blockade changed the standard of care for cHL?20
New therapies in hemophilia: extend the half-life, mimic, or rebalance?20
0.088474035263062